热门资讯> 正文
Jaguar Health Awarded Patent in Jordan for Short Bowel Syndrome Treatment
2024-08-27 22:58
10:58 AM EDT, 08/27/2024 (MT Newswires) -- Jaguar Health (JAGX) said Tuesday its Napo Pharmaceuticals unit received a patent in Jordan for its crofelemer antidiarrheal drug.
The patent covers methods for treating short bowel syndrome, bile acid diarrhea, and diarrhea associated with small intestine resection or gallbladder removal in patients with an inhibitor of chloride-ion transport such as crofelemer, a plant-based prescription medicine, Jaguar said.
Shares of Jaguar Health were down more than 1% in recent trading.
Price: 1.16, Change: -0.01, Percent Change: -1.28
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
